SCHEMBL6576076

SCHEMBL6576076

CN1C2CCCC1(C[C@H]1CO1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576075 1.00
SCHEMBL14755359 0.76
SCHEMBL7327638 0.71 OPRM1 (0.31)
SCHEMBL3979443 0.66 HRH3 (0.38)
Bromide SCHEMBL6890863 0.65 KDM4E (0.37)
SCHEMBL7305562 0.61
SCHEMBL5731681 0.61
SCHEMBL14753162 0.61
SCHEMBL19257758 0.60 SIGMAR1 (0.31)
SCHEMBL4541902 0.59 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1154983-B1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-04-28 EP disclosed
US-6441237-B1 DRUGS; ANTIARRHTHYMIA AGENTS, ANTIISCHEMIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-08-27 US disclosed
EP-1154983-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES Boehringer Ingelheim Pharma KG (DE) 2001-11-21 EP disclosed
WO-2000048987-A1 NOVEL SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-08-24 WO disclosed